Cytokinetics, Incorporated · NASDAQ:CYTK
T. Rowe Price Investment Management, Inc. reported a 14.70% stake in Cytokinetics, Incorporated (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
T. Rowe Price Investment Management, Inc. reported a 14.70% stake in Cytokinetics, Incorporated, 17,602,440 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 14.70%
- Shares
- 17,602,440
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14.70% | 17,602,440 |
Source
Related
- Cytokinetics, Incorporated
- T. Rowe Price Investment Management, Inc.
- Cytokinetics, Incorporated shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Feb 17, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 14, 2025
- Schedule 13G · T. Rowe Price Investment Management, Inc. · May 7, 2025
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026